Engaging Care for HIV-infected Adolescent Females.
Status: | Completed |
---|---|
Conditions: | HIV / AIDS |
Therapuetic Areas: | Immunology / Infectious Diseases |
Healthy: | No |
Age Range: | 13 - 23 |
Updated: | 8/3/2016 |
Start Date: | July 2003 |
End Date: | December 2010 |
Drug Use and HIV-Infected Female Adolescents' Care Use
The proposed multi-site, longitudinal study will examine the correlation of substance use,
mental health disorders, and social networks to engagement in care for HIV-infected
adolescent females, aged 13 years, 0 months - 23 years, 11 months, and suggest ways to
promote adherence and retention in treatment, care, and prevention programs. Qualitative and
quantitative data collection methods will be used with index participants and network
members.
mental health disorders, and social networks to engagement in care for HIV-infected
adolescent females, aged 13 years, 0 months - 23 years, 11 months, and suggest ways to
promote adherence and retention in treatment, care, and prevention programs. Qualitative and
quantitative data collection methods will be used with index participants and network
members.
The primary outcome examined in the proposed study is engagement in care, operationalized as
the number of clinical visits attended. Clinic visits will be monitored on a weekly basis.
Secondary outcomes of interest include medication adherence, sexual risk behaviors, and
substance use. For the quantitative study, formal psychological testing will be conducted
with index adolescent females, and biological specimens will be collected to validate
self-reported drug use. CD-4 counts and viral load will be monitored every three months via
chart review.
Index adolescents will be interviewed every six months (with phone interviews focused on
service utilization at each six month interval midpoint) for eighteen months while network
members will be interviewed at baseline and one year.
Qualitative interviews in the Ethnographic Study will be conducted with a small sub-sample
of index and identified network participants from each site at least monthly for a period of
at least 18 months. Qualitative interviews will be ethnographic in nature and will rely on
participants' life stories and narratives of social experience to supply their content and
to guide their progression.
Qualitative Interviews in the Gender Substudy will be conducted with a subsample of index
participants. These qualitative interviews will focus on issues of gender related
vulnerabilities and will be used to develop a survey to be administered to all index
participants from sites participating in this substudy.
the number of clinical visits attended. Clinic visits will be monitored on a weekly basis.
Secondary outcomes of interest include medication adherence, sexual risk behaviors, and
substance use. For the quantitative study, formal psychological testing will be conducted
with index adolescent females, and biological specimens will be collected to validate
self-reported drug use. CD-4 counts and viral load will be monitored every three months via
chart review.
Index adolescents will be interviewed every six months (with phone interviews focused on
service utilization at each six month interval midpoint) for eighteen months while network
members will be interviewed at baseline and one year.
Qualitative interviews in the Ethnographic Study will be conducted with a small sub-sample
of index and identified network participants from each site at least monthly for a period of
at least 18 months. Qualitative interviews will be ethnographic in nature and will rely on
participants' life stories and narratives of social experience to supply their content and
to guide their progression.
Qualitative Interviews in the Gender Substudy will be conducted with a subsample of index
participants. These qualitative interviews will focus on issues of gender related
vulnerabilities and will be used to develop a survey to be administered to all index
participants from sites participating in this substudy.
Quantitative Study Inclusion Criteria
Index Participants:
1. Female.
2. Age 13 years, 0 months - 23 years, 11 months (364 days).
3. All race/ethnicities.
4. English or Spanish speaking.
5. Non-perinatal, non-transfusion acquired HIV.
6. Unknown transmission status with study personnel approval.
Network Participants:
Parents/Guardians of Index Participants:
1. Know patient's HIV status
2. Male or female.
3. All race/ethnicities
4. English or Spanish speaking.
5. Serve a parental or guardian-like role.
Close Friend of Index Participants:
1. Close friend of index subject.
2. Male or female.
3. Minimum age 13 years, 0 months.
4. All race/ethnicities
5. English or Spanish speaking
Ethnographic Sub-Sample
Inclusion Criteria:
Index Participants:
1. Enrolled in Quantitative NIDA study.
2. English-speaking at Miami, New York, Chicago, and New Orleans sites.
3. English or Spanish-speaking at Los Angeles USC site
Network Participants:
1. English-speaking at Miami, New York, Chicago, and New Orleans sites.
2. English or Spanish-speaking at Los Angeles USC site.
3. Know index serostatus.
Gender Sub-Sample
Inclusion Criteria:
1. Age 18 years, 0 months - 23 years, 11 months.
2. Enrolled in quantitative study.
3. English-speaking.
4. Female.
We found this trial at
5
sites
Montefiore Medical Center As the academic medical center and University Hospital for Albert Einstein College...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials